These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4962727

  • 1. Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients.
    Bartolucci G, Lehmann HE, Ban TA, Lee H.
    Curr Ther Res Clin Exp; 1966 Dec; 8(12):581-4. PubMed ID: 4962727
    [No Abstract] [Full Text] [Related]

  • 2. A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.
    Dehnel LL, Vestre ND, Schiele BC.
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):169-76. PubMed ID: 4967871
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
    Poeldinger W.
    Arzneimittelforschung; 1967 Sep; 17(9):1133-5. PubMed ID: 5632287
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical and EEG study (polygraph recording) of a new neuroleptic drug: Sordinol (clopenthixol)].
    Urbani M, Costa P, Bergonzi P.
    Riv Sper Freniatr Med Leg Alien Ment; 1965 Oct 31; 89(5):1225-50. PubMed ID: 5860488
    [No Abstract] [Full Text] [Related]

  • 7. [On the therapeutic effect of sordinol and fluanxol in the treatment of schizophrenic patients].
    Kontsevoi VA, Panteleeva GP, Zavidovskaia GI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Oct 31; 69(8):1238-43. PubMed ID: 5370166
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Voltage laterality in the EEG of psychiatric patients.
    Serafetinides EA.
    Dis Nerv Syst; 1973 Mar 31; 34(3):190-1. PubMed ID: 4715636
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical physiognomy of chlorprothixene and clopentixol.
    Rimestad S.
    Acta Psychiatr Belg; 1974 Sep 31; 74(5):491-9. PubMed ID: 4471029
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold].
    Náhunek K, Svestka J, Misurec J.
    Act Nerv Super (Praha); 1967 Nov 31; 9(4):404-5. PubMed ID: 4889075
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Controlled studies with thiothixene and perphenazine in schizophrenic psychoses].
    Hádlík J, Svestka J, Náhunek K, Rodová A.
    Act Nerv Super (Praha); 1970 Jan 12; 12(1):60-1. PubMed ID: 4907392
    [No Abstract] [Full Text] [Related]

  • 19. An early clinical evaluation of clopenthixol in treatment-resistant female schizophrenic patients.
    Wolpert A, Sheppard C, Merlis S.
    Am J Psychiatry; 1967 Nov 12; 124(5):702-5. PubMed ID: 4860763
    [No Abstract] [Full Text] [Related]

  • 20. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG, Dencker SJ, Gravem A, Remvig J.
    Acta Psychiatr Scand Suppl; 1980 Nov 12; 279():77-91. PubMed ID: 6996426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.